The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research

BACKGROUND: In the asymptomatic “preclinical” phase of Alzheimer's disease (AD), abnormal biomarkers indicate risk for developing cognitive impairment. Biomarker information is increasingly being disclosed to participants in research settings, and biomarker testing and results disclosure will b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketchum, Fred B., Chin, Nathaniel A., Erickson, Claire, Lambrou, Nickolas H., Basche, Kristin, Gleason, Carey E., Clark, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423755/
https://www.ncbi.nlm.nih.gov/pubmed/37583545
http://dx.doi.org/10.1002/trc2.12416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423755/
https://www.ncbi.nlm.nih.gov/pubmed/37583545
http://dx.doi.org/10.1002/trc2.12416

Ejemplares similares